Interested in learning more about becoming a Presenting Company for the China Healthcare Summit in Shanghai?
APPLY TO PRESENT
Sponsorship Opportunities:Looking for thought leadership or branding opportunities?
BECOME A SPONSOR

China's Innovation Moment

From cross-border deals to newcos, faster clinical data is fueling the China innovation story, turning biopharmas from Shanghai to Beijing into global players. Multinational pharma and Western VCs have been the first to capitalize, sourcing innovation from China at record levels.

But testing faster in humans is also a recipe for Western and Asia biotechs to de-risk their own compounds, working with China partners.

This November, BioCentury, BayHelix and Insights Partner McKinsey & Company invite you to visit Shanghai for the 13th China Healthcare Summit. Get a firsthand look at China's biotech ecosystem and build your network with the right biopharmas, investors and CDMOs.

What Will I Learn? 

  • How are China biotechs generating faster clinical data for their assets?

  • What policies have China regulators adopted to help accelerate R&D?

  • How can I source innovation from China?

  • How can China de-risk Western and Asia assets via faster clinical data?

  • What are the top China assets available for licensing or NewCos?

  • Where is China innovation heading next on targets, modalities and indications?

  • Which CDMOs and service providers can help accelerate my pipeline?

  • What licensing and NewCo opportunities are available in Korea, Singapore and other emerging Asia markets?

Present your Story to VCs and Pharma

Are you a biotech with cutting-edge innovation? Join the Presenting Company Class of 2026 to increase your visibility and drive partnering requests from VCs and BD teams. Limited space - submit your nominations today.

Apply to Present >>

Deliver Thought Leadership

Share your insights, elevate your brand and position yourself as a peer in BioCentury's network of biopharma decision-makers.

Learn More >>